Mesiano S, Young I R, Baxter R C, Hintz R L, Browne C A, Thorburn G D
Endocrinology. 1987 May;120(5):1821-30. doi: 10.1210/endo-120-5-1821.
The role of the pituitary gland in the regulation of skeletal growth and plasma insulin-like growth factor (IGF)-I and IGF-II concentrations in the late gestation sheep fetus has been studied. Singleton fetuses were either hypophysectomized (n = 14) or sham operated (n = 8) between days 110 and 125. Fetal and maternal blood samples were collected three times weekly through the remainder of gestation. In some hypophysectomized fetuses (HXT4 group, n = 4), T4 was administered (100 micrograms L-T4/day) to overcome the hypothyroidism caused by hypophysectomy. The other hypophysectomized fetuses received no replacement therapy (HXNR group, n = 10). Six HXNR fetuses were allowed to remain in utero post term and were killed at day 163 of gestation. All other animals were killed at day 147. All values are group means +/- SE. Hypophysectomized fetuses had significantly shorter limbs and long bones and delayed osseous maturation at term compared to sham controls. Plasma free T4 concentrations in HXT4 fetuses were not significantly different from those measured in sham fetuses (P greater than 0.05). Bone maturation at term was normal in HXT4 fetuses although there was no improvement in limb or bone elongation. Retention of hypophysectomized fetuses in utero until 16 days past term yielded fetuses which were heavier than controls but whose limb and bone lengths were no greater than hypophysectomized fetuses killed at term. Osseous maturation was appropriate for term in five of the six postterm hypophysectomized fetuses. The plasma IGF-I and IGF-II concentrations were not significantly affected by hypophysectomy, hypophysectomy with T4 replacement, gestational age, or prolonged gestation. The plasma IGF-I concentrations in the sham, HXNR, and HXT4 fetuses were 35.4 +/- 6.6, 28.2 +/- 3.0, and 34.4 +/- 1.7 ngeq human (h)IGF-I/ml, and the IGF-II concentrations were 656.3 +/- 59.2, 635.3 +/- 56.3, and 645.5 +/- 71.9 ngeq hIGF-II/ml, respectively, and remained within these ranges throughout the experiment. Fetal IGF-I concentrations were significantly lower than mean maternal IGF-I concentrations (88.0 +/- 6.8 ngeq hIGF-I/ml, P less than 0.05), and fetal IGF-II concentrations were significantly higher than mean maternal IGF-II concentrations (362.4 +/- 24.0 ngeq hIGF-II/ml, P less than 0.05). We conclude that in the late gestation fetal sheep, elongation of the appendicular skeleton is under some direct pituitary control whereas appendicular maturation exhibits some dependence on circulating T4 concentrations.(ABSTRACT TRUNCATED AT 400 WORDS)
研究了垂体在妊娠晚期绵羊胎儿骨骼生长调节以及血浆胰岛素样生长因子(IGF)-I和IGF-II浓度调节中的作用。在妊娠110至125天之间,将单胎胎儿进行垂体切除(n = 14)或假手术(n = 8)。在妊娠剩余时间内,每周采集三次胎儿和母体血样。在一些垂体切除的胎儿(HXT4组,n = 4)中,给予T4(100微克L-T4/天)以克服垂体切除引起的甲状腺功能减退。其他垂体切除的胎儿未接受替代治疗(HXNR组,n = 10)。6只HXNR胎儿在足月后仍留在子宫内,并在妊娠第163天处死。所有其他动物在第147天处死。所有数值均为组均值±标准误。与假手术对照组相比,垂体切除的胎儿肢体和长骨明显较短,足月时骨成熟延迟。HXT4胎儿的血浆游离T4浓度与假手术胎儿测得的浓度无显著差异(P>0.05)。HXT4胎儿足月时骨成熟正常,尽管肢体或骨骼伸长没有改善。将垂体切除的胎儿留在子宫内直至过期16天,得到的胎儿比对照组重,但其肢体和骨骼长度不大于足月时处死的垂体切除胎儿。6只过期垂体切除胎儿中有5只的骨成熟符合足月时的情况。垂体切除、T4替代的垂体切除、胎龄或延长妊娠对血浆IGF-I和IGF-II浓度无显著影响。假手术、HXNR和HXT4胎儿的血浆IGF-I浓度分别为35.4±6.6、28.2±3.0和34.4±1.7纳克当量人(h)IGF-I/毫升,IGF-II浓度分别为656.3±59.2、635.3±56.3和645.5±71.9纳克当量hIGF-II/毫升,并且在整个实验过程中保持在这些范围内。胎儿IGF-I浓度显著低于母体IGF-I平均浓度(88.0±6.8纳克当量hIGF-I/毫升,P<0.05),胎儿IGF-II浓度显著高于母体IGF-II平均浓度(362.4±24.0纳克当量hIGF-II/毫升,P<0.05)。我们得出结论,在妊娠晚期绵羊胎儿中,附属骨骼的伸长受到垂体的一些直接控制,而附属骨骼的成熟表现出对循环T4浓度的某种依赖。(摘要截断于400字)